Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 421 | — | BRIDGEBIO ONCOLOGY THERAPEUT | — | 5,000.0 | $58K | 0.01% | NEW | — | $11.58 | — |
| 422 | AMRN | AMARIN CORP PLC -ADR | Healthcare | 3,534.0 | $58K | 0.01% | NEW | — | $16.38 | -11.2% |
| 423 | REPL | REPLIMUNE GROUP INC | Healthcare | 13,682.0 | $57K | 0.01% | NEW | — | $4.19 | +23.1% |
| 424 | AUTL | AUTOLUS THERAPEUTICS PLC | Healthcare | 35,157.0 | $57K | 0.01% | NEW | — | $1.63 | +1.2% |
| 425 | EDIT | EDITAS MEDICINE INC | Healthcare | 15,762.0 | $55K | 0.01% | NEW | — | $3.47 | -23.1% |
| 426 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 3,367.0 | $55K | 0.01% | NEW | — | $16.24 | +6.5% |
| 427 | — | SCPHARMACEUTICALS INC | — | 9,342.0 | $53K | 0.00% | NEW | — | $5.67 | — |
| 428 | ALEC | ALECTOR INC | Healthcare | 17,741.0 | $53K | 0.00% | NEW | — | $2.96 | -25.3% |
| 429 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 2,000.0 | $52K | 0.00% | NEW | — | $25.93 | -0.7% |
| 430 | VNDA | VANDA PHARMACEUTICALS INC | Healthcare | 10,357.0 | $52K | 0.00% | NEW | — | $4.99 | +23.8% |
| 431 | NMRA | NEUMORA THERAPEUTICS INC | Healthcare | 28,387.0 | $52K | 0.00% | NEW | — | $1.82 | +1.6% |
| 432 | ACIU | AC IMMUNE SA | Healthcare | 17,600.0 | $51K | 0.00% | NEW | — | $2.89 | -1.4% |
| 433 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 15,003.0 | $48K | 0.00% | NEW | — | $3.23 | +10.5% |
| 434 | FHTX | FOGHORN THERAPEUTICS INC | Healthcare | 9,909.0 | $48K | 0.00% | NEW | — | $4.89 | -14.9% |
| 435 | HUMA | HUMACYTE INC | Healthcare | 27,760.0 | $48K | 0.00% | NEW | — | $1.74 | -41.4% |
| 436 | ALLO | ALLOGENE THERAPEUTICS INC | Healthcare | 38,892.0 | $48K | 0.00% | NEW | — | $1.24 | +58.1% |
| 437 | KMTS | KESTRA MEDICAL TECHNOLOGIES | Healthcare | 2,000.0 | $48K | 0.00% | NEW | — | $23.76 | -9.3% |
| 438 | RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | 4,558.0 | $47K | 0.00% | NEW | — | $10.22 | -36.2% |
| 439 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 7,580.0 | $45K | 0.00% | NEW | — | $6.00 | +48.3% |
| 440 | VYGR | VOYAGER THERAPEUTICS INC | Healthcare | 9,723.0 | $45K | 0.00% | NEW | — | $4.67 | -25.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
41.9%
Healthcare
19.3%
Communication Services
11.9%
Consumer Cyclical
11.4%
Financial Services
8.9%
Consumer Defensive
3.1%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%